Abstract | BACKGROUND: RESULTS:
siRNA was transferred to 26% of RT-112Luc cells by UBL and the luciferase activity of RT-112Luc cells was significantly suppressed by UBL using the luciferase siRNA, compared with that using nonspecific siRNA in vitro (p = 0.036). The luciferase activity of RT-112Luc tumor was suppressed by UBL using luciferase siRNA compared with that using nonspecific siRNA 2 days after the in vivo treatment. CONCLUSION: This study showed that UBL is suitable for siRNA transfer to mammalian cells.
|
Authors | Suguru Fujisawa, Hiroshige Arakawa, Ryo Suzuki, Kazuo Maruyama, Tetsuya Kodama, Masahiro Yasunaga, Yoshikatsu Koga, Yasuhiro Matsumura |
Journal | Therapeutic delivery
(Ther Deliv)
Vol. 1
Issue 2
Pg. 247-55
(Aug 2010)
ISSN: 2041-5990 [Print] England |
PMID | 22816131
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Bacterial Proteins
- Liposomes
- Luminescent Proteins
- RNA, Small Interfering
- yellow fluorescent protein, Bacteria
- Luciferases, Firefly
|
Topics |
- Animals
- Bacterial Proteins
(biosynthesis, genetics)
- Cell Line, Tumor
- Female
- Genetic Therapy
(methods)
- Humans
- Liposomes
- Luciferases, Firefly
(biosynthesis, genetics)
- Luminescent Proteins
(biosynthesis, genetics)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- RNA Interference
- RNA, Small Interfering
(metabolism)
- Time Factors
- Transfection
(methods)
- Ultrasonics
- Urinary Bladder Neoplasms
(genetics, metabolism, pathology, therapy)
|